Dr. Katz leads the Cancer Surveillance and Outcomes Research Team (CanSORT), an interdisciplinary group of investigators dedicated to researching cancer quality of care. Our investigators are located at five universities and cancer centers throughout the United States and seek to understand and improve how patients and their providers communicate and make decisions about cancer treatments. CanSORT studies the quality of cancer care across the continuum of care from prevention to survivorship. The team also develops and evaluates interventions to improve cancer care including decision tools for patients and clinicians and dissemination strategies to more quickly move research results to the provider community.
CanSORT investigators are interested in various dimensions of cancer quality of care in diverse populations. We study topics such as appropriate use of treatments; patient perspectives about treatment decision-making and care; the quality of diagnostic tests; and quality of life during treatment and in the survivorship period.